A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer
C80702 is permanently closed to new patient accrual effective, November 20. 2015 at 4:30 PM ET.